Harry Stylli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BIOR | Complete Biora Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Sean...

Progenity Announces Poster Presentations at Digestive Disease Week 2021 Two Abstracts Support Company’s Targeted Therapeutics Program including the Drug Delivery System May 24, 2021 07:30 ET | Source: Progenity, Inc. Progenity, Inc. San Diego, California, UNITED STATES SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the presentation of two posters related to the company’s Targeted Therapeutics program presented at the 2021 Digestive Disease Week® (DDW) Virtual Ev...

Progenity, Inc. (PROG) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Progenity, Inc. (NASDAQ: PROG) Operator Good afternoon everyone. Welcome to the Progenity first-quarter 2021 earnings call. [Operator instructions] And later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator instructions] And I will now turn the call over to Robert Uhl, managing director with Westwicke ICR, Progenity's investor relations firm. Robert Uhl -- Managing Director Thank you,...

Progenity and Ionis Pharmaceuticals Enter into Agreement for Oral Delivery of Antisense Therapies Share Rare Daily Staff Progenity said it entered an agreement with Ionis Pharmaceuticals to evaluate Progenity’s Oral Biotherapeutics Delivery System for oral systemic delivery of Ionis’ antisense oligonucleotides. Ionis’ novel antisense therapies are designed to target mRNA in a highly specific manner and either decrease disease-causing proteins or increase the production of a needed protein. The Oral Biotherapeutics Delivery System (ODBS) is an ingestible capsule based on ...